
Baijayanta Maiti MD PhD
Movement Disorder, Neuromuscular Medicine
Associate Professor of Neurology and Radiology Program Director, Movement Disorders Fellowship Barnes-Jewish Hospital / Washington University in St. Louis School of Medicine.
Join to View Full Profile
4921 Parkview PlDiv Neurology Movement Disorders 7TH FLSaint Louis, MO 63110
Phone+1 314-362-6908
Fax+1 314-747-3258
Dr. Maiti is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Education & Training
- Washington University/B-JH/SLCH ConsortiumFellowship, Neuromuscular Medicine (Neurology), 2014 - 2016
- Washington University/B-JH/SLCH ConsortiumFellowship, Neuromuscular Medicine (Neurology), 2013 - 2014
- Washington University/B-JH/SLCH ConsortiumResidency, Neurology, 2009 - 2013
- University of UtahPhD, Human Genetics, 2003 - 2009
- Medical College and Hospital KolkataClass of 2003
Certifications & Licensure
- IL State Medical License 2021 - 2026
- MO State Medical License 2013 - 2026
- American Board of Psychiatry and Neurology Neurology
- American Board of Psychiatry and Neurology Neuromuscular Medicine
Publications & Presentations
PubMed
- Genetic Analysis of the X Chromosome Associates Loci with Progression of Parkinson's Disease.Yu Liao, Hao Wu, Junhao Wang, Jean-Christophe Corvol, Jodi Maple-Grødem
Movement Disorders. 2025-06-03 - Impact of Y chromosome loss on the risk of Parkinson's disease and progression.Junhao Wang, Xinyi Chen, Wenxuan Du, Cha Lin, Yu Liao
Ebiomedicine. 2025-05-29 - Radiation dosimetry of [C]TZ1964B as determined by whole-body PET imaging of nonhuman primates.Baijayanta Maiti, Noah L Goldman, Mahdjoub Hamdi, Jason Lenox-Krug, Morvarid Karimi
EJNMMI Research. 2025-05-14
Press Mentions
- Blood Pressure Medicine Dynacirc Falls Short in Phase 3 Trial for Early Parkinson’sApril 2nd, 2020
Grant Support
- Cerebellar cholinergic connections as a biomarker of dementia and gait impairment in Parkinson diseaseWASHINGTON UNIVERSITY2022–2027
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: